Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Debt to equity
Agilent Technologies, Inc.'s debt to equity at the end of the quarter to 31 July 2026 was 0.5×, up 0.0× from fiscal 2025 (0.5×). Over the past ten years it has ranged from 0.4× (fiscal 2017) to 0.6× (fiscal 2024); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.5× | (20.21%) |
| FY2024 | 0.6× | 21.20% |
| FY2023 | 0.5× | (9.18%) |
| FY2022 | 0.5× | 1.74% |
| FY2021 | 0.5× | 8.04% |
| FY2020 | 0.5× | 24.26% |
| FY2019 | 0.4× | (4.17%) |
| FY2018 | 0.4× | 5.66% |
| FY2017 | 0.4× | (16.93%) |
| FY2016 | 0.4× | 12.98% |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jul 2026 | 0.5× | 15.55% |
| Apr 2026 | 0.4× | (2.97%) |
| Jan 2026 | 0.4× | (2.43%) |
| Oct 2025 | 0.5× | (13.96%) |
| 43 more quarters | Free account |
Against its own ten years
Low 0.4×
High 0.6×
Ten-year median
0.5×
Current reading's percentile
55
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GH Guardant Health, Inc. compare | −6.7× |
| NTRA Natera, Inc. compare | 0.0× |
| IDXX IDEXX Laboratories, Inc. compare | 0.3× |
| WAT Waters Corporation compare | 0.3× |
| A Agilent Technologies, Inc. | 0.5× |
| ILMN Illumina, Inc. compare | 0.5× |
| DGX Quest Diagnostics Incorporated compare | 0.7× |
| IQV IQVIA Holdings Inc. compare | 2.5× |
| MTD Mettler-Toledo International, Inc. compare | 165× |
| Diagnostics & Research industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement